Expectations trend
FY2028 · fiscal year ending 2028-10-31 · fmp
$-0.64 → $-0.64 · observed estimates
NASDAQIndustrialsElectrical Equipment & PartsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for FCEL yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Cash flow from operations improves to less negative than -$27M in 2026-Q2 | Cash flow from operations is less negative, improving from -$45.7M to -$27.3M. | Under Pressure | cash flow from operations worsens beyond -$35 million in 2026-Q2 | Cash from operations: $-12.204M FY2026-Q3; GAAP. Published target: >= -$27 million. The stored target says 2026-Q2; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Sep 2, 2026-12,204,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-10-31 · fmp
$-0.64 → $-0.64 · observed estimates
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative growth business rather than a durable compounder today. The thesis is in a watch state: recent performance is weak, management execution is volatile, and the evidence is mixed.
FCEL trades at a durable premium of about 1.93 times its peers, despite ongoing losses, and the model confidence is low. The expectations gap is negative, suggesting expectations are demanding relative to the evidence; the premium is tagged as justified, with low fragility in the current assessment.
Near term, earnings risk is elevated after a recent miss and a pattern of misses, while company momentum has weakened. Revenue declined between the reported quarters, even as a data center agreement advanced; operating loss narrowed, but Adjusted EBITDA loss widened. Positive Adjusted EBITDA remains a stated goal for fiscal Q4 2027, and the Torrington capacity expansion is scheduled for completion by June 2028.
The multi-year view depends on converting commercial demand into delivered revenue, raising production capacity, and reducing costs enough to reach positive Adjusted EBITDA. A guidance cut on the next call would add to concerns, while continued strength or weakness from sector bellwethers ETN, VRT, and BE could shape the wider Industrials backdrop.
Over the next 1 to 3 years, FCEL’s thesis remains uncertain and execution-dependent, with high risk and limited proof that commercial activity is translating into improving financial results. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Capital expenditures remain within $200M-$275M range without excessive dilution |
| A supporting condition in FuelCell Energy Inc's published investment case. The stated target is Capex between $200M and $275M; dilution limited. |
| Under Pressure |
| capital raise exceeds $275M or dilutes shareholders beyond 10% |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Operating losses improve to less than -$78M in 2026-Q2 | Operating losses have improved from -$95M to -$78M, showing progress. | Broken | operating losses worsen beyond -$85 million in 2026-Q2 | Operating income: $-46.66M FY2026-Q3; GAAP. Published target: <= -$78 million. The stored target says 2026-Q2; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Sep 2, 2026-46,660,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue grows to at least $155M in FY26 | A primary condition in FuelCell Energy Inc's published investment case. The stated target is >= $155 million. | Broken | revenue falls below $140 million in FY26 | Revenue: $33.001M FY2026-Q3; GAAP. Published target: >= $155 million. Annual target cannot be compared with a quarterly or TTM observation. Sep 2, 202633,001,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.42B → $0.42B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-11-01 | $-0.64 | $419,281,370 | 5 / 8 |
| 2026-11-02 | $-0.64 | $419,281,370 | 5 / 8 |
| 2026-11-03 | $-0.64 | $419,281,370 | 5 / 8 |
| 2026-11-04 | $-0.64 | $419,281,370 | 5 / 8 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 6 Buy / Strong Buy · 3 Hold · 2 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Dec 17, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.